6 results
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Fremanezumab for ... End Points #EBM #Neuro ... #IM #Fremanezumab ... #Migraine #CGRP ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Fremanezumab for ... End Points #EBM #Neuro ... #IM #Fremanezumab ... #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
Fremanezumab for ... Trial Group #EBM #Neuro ... #IM #Fremanezumab ... #Migraine #CGRP ... #NEJM
Original and Simplified PESI PulmonaryEmbolism #Diagnosis #EM #IM #PCC #PESI #sPESI #risk #score #PE #Table
and Simplified PESI ... PulmonaryEmbolism #Diagnosis ... #EM #IM #PCC #PESI ... #sPESI #risk #score
Pulmonary Embolism Severeity Index - estimates 30d mortality #Diagnosis #Management #EM #IM #PCC #PESI #sPESI #risk
30d mortality #Diagnosis ... Management #EM #IM ... #PCC #PESI #sPESI
Original and Simplified PESI Prediction Rule Test Characteristics for 30-Day Mortality
#EBM #Diagnosis	#EM #IM #PCC	#PESI #sPESI #risk
and Simplified PESI ... Mortality #EBM #Diagnosis ... #EM #IM #PCC #PESI ... #sPESI #risk #score